As for the DUAL-1 study, the primary endpoint was to prove non-inferiority of the combination compared to glargine and superiority compared to lixisenatide
Measuring Lp(a) at least once in adulthood may help identify inherited risk that is not apparent from a standard lipid panel
Localized itching or hives at the injection site may indicate a reaction to the medication itself rather than injection trauma
Characteristics of triple seronegative myasthenia gravis: a single center experience
Pharma determines access, pricing, supply, and exits, the four pillars of GLP-1 market stability.(e.g., Roche, AbbVie, Novo Nordisk) They control the drug pipeline and reimbursement Pharmas licensing, M&A, and distribution decisions determine what products clinicians can prescribe and what insurers will cover
Imaging Methods Detection of the lesion by mammography, breast ultrasound, or magnetic resonance (MRI) imaging